• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞通过 14-HDHA 和 17-HDHA 来预防肺动脉高压。

Eosinophils protect against pulmonary hypertension through 14-HDHA and 17-HDHA.

机构信息

State Key Laboratory of Medical Molecular Biology, Haihe Laboratory of Cell Ecosystem, Dept of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

These authors contributed equally to this manuscript.

出版信息

Eur Respir J. 2023 Mar 2;61(3). doi: 10.1183/13993003.00582-2022. Print 2023 Mar.

DOI:10.1183/13993003.00582-2022
PMID:36423907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9978164/
Abstract

BACKGROUND

Pulmonary hypertension (PH) is a life-threatening disease featuring pulmonary vessel remodelling and perivascular inflammation. The effect, if any, of eosinophils (EOS) on the development of PH remains unclear.

METHODS

EOS infiltration and chemotaxis were investigated in peripheral blood and lung tissues from pulmonary arterial hypertension (PAH) patients without allergic history and from sugen/hypoxia-induced PH mice. The role of EOS deficiency in PH development was investigated using deletion (ΔdblGATA) mice and anti-interleukin 5 antibody-treated mice and rats. Ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was conducted to identify the critical oxylipin molecule(s) produced by EOS. Culture supernatants and lysates of EOS were collected to explore the mechanisms in co-culture cell experiments.

RESULTS

There was a lower percentage of EOS in peripheral blood but higher infiltration in lung tissues from PAH patients and PH mice. PAH/PH lungs showed increased EOS-related chemokine expression, mainly C-C motif chemokine ligand 11 derived from adventitial fibroblasts. EOS deficiency aggravated PH in rodents, accompanied by increased neutrophil and monocyte/macrophage infiltration. EOS highly expressed arachidonate 15-lipoxygenase (ALOX15). 14-hydroxy docosahexaenoic acid (14-HDHA) and 17-HDHA were critical downstream oxylipins produced by EOS, which showed anti-inflammatory effects on recruitment of neutrophils and monocytes/macrophages through N-formyl peptide receptor 2. They also repressed pulmonary artery smooth muscle cell (PASMC) proliferation by activating peroxisome proliferator-activated receptor γ and blunting Stat3 phosphorylation.

CONCLUSIONS

In PH development without external stimuli, peripheral blood exhibits a low EOS level. EOS play a protective role by suppressing perivascular inflammation and maintaining PASMC homeostasis 14/17-HDHA.

摘要

背景

肺动脉高压(PH)是一种危及生命的疾病,其特征是肺血管重塑和血管周围炎症。嗜酸性粒细胞(EOS)对 PH 发展的影响尚不清楚。

方法

研究了无过敏史的肺动脉高压(PAH)患者和 SuGEN/低氧诱导的 PH 小鼠的外周血和肺组织中 EOS 的浸润和趋化作用。利用缺失(ΔdblGATA)小鼠和抗白细胞介素 5 抗体治疗的小鼠和大鼠研究了 EOS 缺乏在 PH 发展中的作用。采用超高效液相色谱-串联质谱(UHPLC-MS/MS)鉴定 EOS 产生的关键氧化脂分子。在共培养细胞实验中,收集培养上清液和 EOS 裂解物以探索机制。

结果

PAH 患者和 PH 小鼠的外周血中 EOS 百分比较低,但肺组织中浸润较多。PAH/PH 肺组织中 EOS 相关趋化因子表达增加,主要来自外膜成纤维细胞的 C-C 基序趋化因子配体 11。EOS 缺乏加重了啮齿动物的 PH,同时伴有中性粒细胞和单核细胞/巨噬细胞浸润增加。EOS 高度表达花生四烯酸 15-脂氧合酶(ALOX15)。14-羟基二十二碳六烯酸(14-HDHA)和 17-HDHA 是 EOS 产生的关键下游氧化脂,通过 N-甲酰肽受体 2 对中性粒细胞和单核细胞/巨噬细胞的募集显示出抗炎作用。它们还通过激活过氧化物酶体增殖物激活受体 γ 和抑制 Stat3 磷酸化来抑制肺动脉平滑肌细胞(PASMC)增殖。

结论

在没有外部刺激的 PH 发展过程中,外周血表现出低 EOS 水平。EOS 通过抑制血管周围炎症和维持 PASMC 稳态发挥保护作用,14/17-HDHA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/f3b083063b5d/ERJ-00582-2022.08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/734096036a92/ERJ-00582-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/0ac0253fb844/ERJ-00582-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/b79eea7dffa8/ERJ-00582-2022.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/3a5f62cc7ec7/ERJ-00582-2022.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/5634e7e627b7/ERJ-00582-2022.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/4bb00cb4f22b/ERJ-00582-2022.06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/5b0b190d5990/ERJ-00582-2022.07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/f3b083063b5d/ERJ-00582-2022.08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/734096036a92/ERJ-00582-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/0ac0253fb844/ERJ-00582-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/b79eea7dffa8/ERJ-00582-2022.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/3a5f62cc7ec7/ERJ-00582-2022.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/5634e7e627b7/ERJ-00582-2022.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/4bb00cb4f22b/ERJ-00582-2022.06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/5b0b190d5990/ERJ-00582-2022.07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0449/9978164/f3b083063b5d/ERJ-00582-2022.08.jpg

相似文献

1
Eosinophils protect against pulmonary hypertension through 14-HDHA and 17-HDHA.嗜酸性粒细胞通过 14-HDHA 和 17-HDHA 来预防肺动脉高压。
Eur Respir J. 2023 Mar 2;61(3). doi: 10.1183/13993003.00582-2022. Print 2023 Mar.
2
Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.阻断 JAK2 可通过抑制肺动脉平滑肌细胞增殖来保护小鼠免受低氧诱导的肺动脉高压。
Cell Prolif. 2020 Feb;53(2):e12742. doi: 10.1111/cpr.12742. Epub 2020 Jan 14.
3
Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.嗜酸性粒细胞在嗜酸性粒细胞炎症诱导的肺动脉高压小鼠模型中对肺小动脉重塑是必需的。
Am J Physiol Lung Cell Mol Physiol. 2011 Dec;301(6):L927-36. doi: 10.1152/ajplung.00049.2011. Epub 2011 Sep 9.
4
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.晚期糖基化终产物受体在肺动脉高压发病机制中的关键作用。
J Am Heart Assoc. 2013 Jan 16;2(1):e005157. doi: 10.1161/JAHA.112.005157.
5
Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.硒蛋白 P 促进肺动脉高压的发生:可能的新型治疗靶点。
Circulation. 2018 Aug 7;138(6):600-623. doi: 10.1161/CIRCULATIONAHA.117.033113.
6
Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.平滑肌细胞特异性 FoxM1 控制低氧诱导的肺动脉高压。
Cell Signal. 2018 Nov;51:119-129. doi: 10.1016/j.cellsig.2018.08.003. Epub 2018 Aug 6.
7
CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.CCR2/CCR5 介导的肺动脉高压中巨噬细胞-平滑肌细胞串扰。
Eur Respir J. 2019 Oct 10;54(4). doi: 10.1183/13993003.02308-2018. Print 2019 Oct.
8
PAR-2 inhibition reverses experimental pulmonary hypertension.PAR-2 抑制可逆转实验性肺动脉高压。
Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.
9
STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.STARS基因敲除通过抑制肺动脉平滑肌细胞增殖减轻缺氧诱导的肺动脉高压。
Biomed Pharmacother. 2017 Mar;87:397-404. doi: 10.1016/j.biopha.2016.12.126. Epub 2017 Jan 6.
10
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.CX3CL1/CX3CR1和CCL2/CCR2趋化因子系统在低氧性肺动脉高压中的作用
Am J Respir Cell Mol Biol. 2017 May;56(5):597-608. doi: 10.1165/rcmb.2016-0201OC.

引用本文的文献

1
EPA-lactone derivative, 5,6-diHETE lactone, improves pulmonary arterial hypertension in a monocrotaline-induced model.EPA-内酯衍生物,5,6-二羟基二十碳四烯酸内酯,可改善由野百合碱诱导模型中的肺动脉高压。
Front Pharmacol. 2025 Jul 10;16:1621030. doi: 10.3389/fphar.2025.1621030. eCollection 2025.
2
Neutrophil-Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension.由S100A9介导的中性粒细胞与内皮细胞相互作用促进肺动脉高压时的肺血管重塑。
Adv Sci (Weinh). 2025 Aug;12(31):e04397. doi: 10.1002/advs.202504397. Epub 2025 Jun 10.
3
Association of echocardiographic pulmonary hypertension with all-cause mortality in hospitalized AECOPD patients.

本文引用的文献

1
Eosinophil extracellular traps drive asthma progression through neuro-immune signals.嗜酸性粒细胞胞外陷阱通过神经免疫信号驱动哮喘进展。
Nat Cell Biol. 2021 Oct;23(10):1060-1072. doi: 10.1038/s41556-021-00762-2. Epub 2021 Oct 6.
2
Development of an Optimized Culture System for Generating Mouse Alveolar Macrophage-like Cells.优化的生成鼠肺泡巨噬细胞样细胞的培养体系的建立。
J Immunol. 2021 Sep 15;207(6):1683-1693. doi: 10.4049/jimmunol.2100185. Epub 2021 Aug 16.
3
Pulmonary hypertension in eosinophilic noneosinophilic COPD.嗜酸性粒细胞性和非嗜酸性粒细胞性慢性阻塞性肺疾病中的肺动脉高压
超声心动图诊断的肺动脉高压与住院慢性阻塞性肺疾病急性加重期患者全因死亡率的关系
Int J Cardiol Heart Vasc. 2025 Mar 29;58:101661. doi: 10.1016/j.ijcha.2025.101661. eCollection 2025 Jun.
4
Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension.解析系统性红斑狼疮相关肺动脉高压的转录组图谱。
Respir Res. 2025 Mar 18;26(1):106. doi: 10.1186/s12931-025-03169-x.
5
Quantitative CT imaging characteristics of patients with chronic obstructive pulmonary disease with different eosinophil levels: a retrospective observational study using linked data from a tertiary hospital in China.不同嗜酸性粒细胞水平的慢性阻塞性肺疾病患者的定量CT成像特征:一项利用中国一家三级医院的关联数据进行的回顾性观察研究
BMJ Open. 2025 Feb 19;15(2):e088887. doi: 10.1136/bmjopen-2024-088887.
6
Associations between omega-3 fatty acid-derived lipid mediators and markers of inflammation in older subjects with low-grade chronic inflammation.ω-3脂肪酸衍生的脂质介质与患有轻度慢性炎症的老年受试者炎症标志物之间的关联。
Prostaglandins Other Lipid Mediat. 2025 Jan;176:106948. doi: 10.1016/j.prostaglandins.2025.106948. Epub 2025 Jan 3.
7
Identification of fatty acid metabolism signature genes in patients with pulmonary arterial hypertension using WGCNA and machine learning.利用 WGCNA 和机器学习鉴定肺动脉高压患者脂肪酸代谢特征基因。
J Int Med Res. 2024 Sep;52(9):3000605241277740. doi: 10.1177/03000605241277740.
8
Ellagic acid-enhanced biocompatibility and bioactivity in multilayer core-shell gold nanoparticles for ameliorating myocardial infarction injury.鞣花酸增强多层核壳结构金纳米粒子的生物相容性和生物活性,用于改善心肌梗死损伤。
J Nanobiotechnology. 2024 Sep 11;22(1):554. doi: 10.1186/s12951-024-02796-8.
9
Emerging mechanisms of obesity-associated immune dysfunction.肥胖相关免疫功能障碍的新兴机制。
Nat Rev Endocrinol. 2024 Mar;20(3):136-148. doi: 10.1038/s41574-023-00932-2. Epub 2023 Dec 21.
10
CC chemokines Modulate Immune responses in Pulmonary Hypertension.CC 趋化因子调节肺动脉高压中的免疫反应。
J Adv Res. 2024 Sep;63:171-186. doi: 10.1016/j.jare.2023.10.015. Epub 2023 Nov 4.
ERJ Open Res. 2021 Mar 8;7(1). doi: 10.1183/23120541.00772-2020. eCollection 2021 Jan.
4
Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production.嗜酸性粒细胞通过 ST2 依赖性 IL-13 产生减轻小鼠肝缺血再灌注损伤。
Sci Transl Med. 2021 Feb 3;13(579). doi: 10.1126/scitranslmed.abb6576.
5
Eosinophils improve cardiac function after myocardial infarction.嗜酸性粒细胞可改善心肌梗死后的心功能。
Nat Commun. 2020 Dec 16;11(1):6396. doi: 10.1038/s41467-020-19297-5.
6
PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.PPARγ-p53 介导的血管再生程序逆转肺动脉高压。
Circ Res. 2021 Feb 5;128(3):401-418. doi: 10.1161/CIRCRESAHA.119.316339. Epub 2020 Dec 16.
7
Eosinophils Protect Mice From Angiotensin-II Perfusion-Induced Abdominal Aortic Aneurysm.嗜酸性粒细胞可保护小鼠免于血管紧张素-II 灌注诱导的腹主动脉瘤。
Circ Res. 2021 Jan 22;128(2):188-202. doi: 10.1161/CIRCRESAHA.120.318182. Epub 2020 Nov 6.
8
Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.消退素D1与ALX/FPR2受体相互作用在血红蛋白诱导的小胶质细胞炎症反应和神经元损伤中的作用
J Neuroinflammation. 2020 Aug 14;17(1):239. doi: 10.1186/s12974-020-01918-x.
9
Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age.嗜酸性粒细胞调节脂肪组织炎症,维持老年的身体和免疫健康。
Nat Metab. 2020 Aug;2(8):688-702. doi: 10.1038/s42255-020-0228-3. Epub 2020 Jul 6.
10
A new dawn for eosinophils in the tumour microenvironment.肿瘤微环境中嗜酸性粒细胞的新曙光。
Nat Rev Cancer. 2020 Oct;20(10):594-607. doi: 10.1038/s41568-020-0283-9. Epub 2020 Jul 16.